Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 1.00 |
| ▸ | GBA1 | P04062 | 2/20 | 1.00 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.47 |
| ▸ | MANBA | O00462 | 2/20 | 0.47 |
| ▸ | IDUA | P35475 | 1/20 | 0.47 |
| ▸ | THRB | P10828 | 1/20 | 0.47 |
| ▸ | GUSB | P08236 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.38 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.38 |
| ▸ | OGA | O60502 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | PYGB | P11216 | 2/20 | 0.37 |
| ▸ | PYGL | P06737 | 1/20 | 0.37 |
| ▸ | PYGM | P11217 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Gluconolactone SCHEMBL18465607 | 1.00 | LMNA (1.00) | LMNAGBA1HIF1AMANBAIDUA | |
| Gluconolactone SCHEMBL333412 | 1.00 | LMNA (1.00) | LMNAGBA1HIF1AMANBAIDUA | |
| Gluconolactone SCHEMBL2466472 | 1.00 | LMNA (1.00) | LMNAGBA1HIF1AMANBAIDUA | |
| Gluconolactone SCHEMBL7148519 | 1.00 | LMNA (1.00) | LMNAGBA1HIF1AMANBAIDUA | |
| Gluconolactone SCHEMBL17068350 | 1.00 | LMNA (1.00) | LMNAGBA1HIF1AMANBAIDUA | |
| Gluconolactone SCHEMBL15631270 | 1.00 | LMNA (1.00) | LMNAGBA1HIF1AMANBAIDUA | |
| Gluconolactone SCHEMBL24637666 | 1.00 | LMNA (1.00) | LMNAGBA1HIF1AMANBAIDUA | |
| Gluconolactone SCHEMBL15631261 | 1.00 | LMNA (1.00) | LMNAGBA1HIF1AMANBAIDUA | |
| Gluconolactone SCHEMBL15631260 | 1.00 | LMNA (1.00) | LMNAGBA1HIF1AMANBAIDUA | |
| Gluconolactone SCHEMBL15631258 | 1.00 | LMNA (1.00) | LMNAGBA1HIF1AMANBAIDUA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140087944-A1 | COMPOSITIONS AND METHODS FOR ENHANCING PLANT GROWTH | NOVOZYMES BIOAG A/S (DK) | 2014-03-27 | — | — | US | disclosed |
| US-20140087944-A1 | COMPOSITIONS AND METHODS FOR ENHANCING PLANT GROWTH | NOVOZYMES BIOAG A/S (DK) | 2014-03-27 | — | — | US | disclosed |
| EP-1940348-B1 | A COMPOSITION COMPRISING A COUPLED ENZYME SYSTEM | DANISCO (DK) | 2011-09-14 | — | — | EP | disclosed |
| US-20090142281-A1 | Composition Comprising A Coupled Enzyme System | DUPONT NUTRITION BIOSCIENCES APS (DK) | 2009-06-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090142281-A1 | Composition Comprising A Coupled Enzyme System | LPO, PRDX3, MPO | LMNA 4691/4885GBA1 1256/4885HIF1A 2054/4885 |
| US-20140087944-A1 | COMPOSITIONS AND METHODS FOR ENHANCING PLANT GROWTH | PGLS, AGL, GALK1 | LMNA 2874/4885GBA1 169/4885HIF1A 771/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.